Personalis, Inc. Comprehensive Income
Personalis, Inc. (PSNL) reported Comprehensive Income of -$31.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$31.73M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$30.21M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$23.79M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$21.59M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$81.14M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$81.08M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$107.61M.
- Personalis, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$114.06M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$31.73M 10-Q · filed 2026-08-04 | -$61.94M 10-Q · filed 2026-08-04 | -$85.73M derived: sum of 3 quarters · filed 2026-08-04 | -$107.32M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$30.21M 10-Q · filed 2026-05-07 | -$54.00M derived: sum of 2 quarters · filed 2026-05-07 | -$75.59M derived: sum of 3 quarters · filed 2026-05-07 | -$95.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$23.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$45.38M derived: sum of 2 quarters · filed 2026-02-26 | -$65.40M derived: sum of 3 quarters · filed 2026-08-04 | -$81.14M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$21.59M 10-Q · filed 2025-11-04 | -$41.61M derived: sum of 2 quarters · filed 2026-08-04 | -$57.35M 10-Q · filed 2025-11-04 | -$73.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$20.02M 10-Q · filed 2026-08-04 | -$35.76M 10-Q · filed 2026-08-04 | -$52.30M derived: sum of 3 quarters · filed 2026-08-04 | -$91.18M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$15.74M 10-Q · filed 2026-05-07 | -$32.28M derived: sum of 2 quarters · filed 2026-05-07 | -$71.16M derived: sum of 3 quarters · filed 2026-05-07 | -$83.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$16.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$55.42M derived: sum of 2 quarters · filed 2026-02-26 | -$68.21M derived: sum of 3 quarters · filed 2026-02-26 | -$81.08M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$38.88M 10-Q · filed 2025-11-04 | -$51.68M derived: sum of 2 quarters · filed 2025-11-04 | -$64.55M 10-Q · filed 2025-11-04 | -$91.05M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$12.80M 10-Q · filed 2025-08-05 | -$25.67M 10-Q · filed 2025-08-05 | -$52.17M derived: sum of 3 quarters · filed 2025-08-05 | -$81.26M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$12.87M 10-Q · filed 2025-05-06 | -$39.38M derived: sum of 2 quarters · filed 2025-05-06 | -$68.46M derived: sum of 3 quarters · filed 2025-05-06 | -$92.28M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$26.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$55.59M derived: sum of 2 quarters · filed 2025-02-27 | -$79.40M derived: sum of 3 quarters · filed 2025-02-27 | -$107.61M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$29.09M 10-Q · filed 2024-11-06 | -$52.90M derived: sum of 2 quarters · filed 2024-11-06 | -$81.10M 10-Q · filed 2024-11-06 | -$111.66M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$23.81M 10-Q · filed 2024-08-07 | -$52.02M 10-Q · filed 2024-08-07 | -$82.57M derived: sum of 3 quarters · filed 2024-08-07 | -$109.22M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$28.20M 10-Q · filed 2024-05-08 | -$58.76M derived: sum of 2 quarters · filed 2024-05-08 | -$85.41M derived: sum of 3 quarters · filed 2024-05-08 | -$113.34M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$30.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$57.21M derived: sum of 2 quarters · filed 2024-02-28 | -$85.14M derived: sum of 3 quarters · filed 2024-02-28 | -$114.06M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$26.65M 10-Q · filed 2023-11-07 | -$54.59M derived: sum of 2 quarters · filed 2023-11-07 | -$83.50M 10-Q · filed 2023-11-07 | -$103.88M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$27.93M 10-Q · filed 2023-08-08 | -$56.85M 10-Q · filed 2023-08-08 | -$77.23M derived: sum of 3 quarters · filed 2024-02-28 | -$94.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$28.92M 10-Q · filed 2023-05-03 | -$49.30M derived: sum of 2 quarters · filed 2024-02-28 | -$66.97M derived: sum of 3 quarters · filed 2024-02-28 | -$81.90M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$20.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$38.05M derived: sum of 2 quarters · filed 2024-02-28 | -$52.98M derived: sum of 3 quarters · filed 2024-02-28 | -$65.41M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$17.68M 10-Q · filed 2022-11-02 | -$32.61M derived: sum of 2 quarters · filed 2022-11-02 | -$45.04M 10-Q · filed 2022-11-02 | -$58.39M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$14.93M 10-Q · filed 2022-08-03 | -$27.36M 10-Q · filed 2022-08-03 | -$40.72M derived: sum of 3 quarters · filed 2023-02-23 | -$50.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$12.43M 10-Q · filed 2022-05-04 | -$25.79M derived: sum of 2 quarters · filed 2023-02-23 | -$35.40M derived: sum of 3 quarters · filed 2023-02-23 | -$44.62M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$22.97M derived: sum of 2 quarters · filed 2023-02-23 | -$32.19M derived: sum of 3 quarters · filed 2023-02-23 | -$41.25M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$9.61M 10-Q · filed 2021-11-04 | -$18.84M derived: sum of 2 quarters · filed 2021-11-04 | -$27.90M 10-Q · filed 2021-11-04 | -$34.52M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$9.22M 10-Q · filed 2021-08-04 | -$18.28M 10-Q · filed 2021-08-04 | -$24.90M derived: sum of 3 quarters · filed 2022-02-24 | -$31.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$9.06M 10-Q · filed 2021-05-05 | -$15.68M derived: sum of 2 quarters · filed 2022-02-24 | -$22.58M derived: sum of 3 quarters · filed 2022-02-24 | -$28.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$13.52M derived: sum of 2 quarters · filed 2022-02-24 | -$19.41M derived: sum of 3 quarters · filed 2022-02-24 | -$25.07M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$6.90M 10-Q · filed 2020-11-05 | -$12.78M derived: sum of 2 quarters · filed 2020-11-05 | -$18.45M 10-Q · filed 2020-11-05 | -$22.01M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$5.88M 10-Q · filed 2020-08-06 | -$11.55M 10-Q · filed 2020-08-06 | -$15.11M derived: sum of 3 quarters · filed 2021-02-25 | -$18.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$5.67M 10-Q · filed 2020-05-07 | -$9.23M derived: sum of 2 quarters · filed 2021-02-25 | -$12.87M derived: sum of 3 quarters · filed 2021-02-25 | -$20.19M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$7.20M derived: sum of 2 quarters · filed 2021-02-25 | -$14.52M derived: sum of 3 quarters · filed 2021-02-25 | -$19.89M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$3.64M 10-Q · filed 2019-11-13 | -$10.96M derived: sum of 2 quarters · filed 2019-11-13 | -$16.33M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$7.32M 10-Q · filed 2019-08-13 | -$12.69M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | -$23.59M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |